【記者柯安聰台北報導】藥祇生醫（7878）將於11月27日以每股參考價120元登錄興櫃，以「維護胰島細胞功能和數量」為核心，開發逆轉糖尿病新藥。公司以創新的核心技術，運用分子對接與蛋白標靶平台研發小分子新藥，其中旗艦產品「PS1」為全球首創（First-in-class）標靶在蛋白雙硫異構酶（PDIA4）之新藥，具備逆轉糖尿病的潛力，目前公司正攜手資本市場募集資金，加速推進臨床試驗與全球授權布局。
“His administration has a new sex scandal that for once has nothing to do with him,” Kimmel said, referring to reports that ...
Back in 2018, Adam Levine of Maroon 5 posted this now-deleted Notes app letter to MTV on his Instagram, enraged that Childish ...
If you're an American and have been paying attention, then you're likely aware of the Trump administration's raids on ...
Little terns are a protected species, and dogs are prohibited from Karagi Point at any time. Disturbance to endangered ...
The Reform UK leader is facing criticism saying he can't remember making racist and antisemitic remarks during his time at ...
Scot D. Thompson, 65, is facing criminal charges after shooting and killing two of his brothers, police allege ...
A Toronto man who claimed a $1-million lottery prize has been charged with keeping the winnings for himself instead of ...
Defense Secretary Pete Hegseth wants the U.S. military to cut all ties with Scouting America, the organization formerly known ...
Estonia is warily watching Russia and learning from Ukraine. It is now pursuing six more HIMARS, saying deep strike abilities ...
An Ontario man is facing charges after he allegedly claimed to be the sole winner of a $1-million group lottery ticket.
Also in Community: I Asked ChatGPT To Badly Describe Taylor Swift Songs! Can You Guess Which One It's Describing?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback